In fibromyalgia, amitriptyline is comparable to FDA-approved drugs for symptoms and acceptability
- PMID: 36191311
- DOI: 10.7326/J22-0071
In fibromyalgia, amitriptyline is comparable to FDA-approved drugs for symptoms and acceptability
Abstract
Farag HM, Yunusa I, Goswami H, et al. Comparison of amitriptyline and US Food and Drug Administration-approved treatments for fibromyalgia: a systematic review and network meta-analysis. JAMA Netw Open. 2022;5:e2212939. 35587348.
Comment on
-
Comparison of Amitriptyline and US Food and Drug Administration-Approved Treatments for Fibromyalgia: A Systematic Review and Network Meta-analysis.JAMA Netw Open. 2022 May 2;5(5):e2212939. doi: 10.1001/jamanetworkopen.2022.12939. JAMA Netw Open. 2022. PMID: 35587348 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical